Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

Husam Ghanim, PhD

  • Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors AND Adiposity in Type 2 Diabetic Males with Hypogonadotrophic Hypogonadism. Husam Ghanim (Co-Investigator). AbbVie Incorporated. 5/1/2013-11/1/2017.
  • Liraglutide as an Additional treatment in Type 1 diabetes. Husam Ghanim (Co-Investigator). NIH/NIDDK. 8/1/2012-7/1/2017.